The Conference on Retroviruses and Opportunistic Infections (CROI) is the leading global meeting for HIV research, bringing together over 4,000 experts from around the world. It serves as a platform for researchers to translate laboratory and clinical discoveries into meaningful advancements in the fight against the HIV pandemic. CROI has played a pivotal role in showcasing groundbreaking research, ultimately accelerating progress in HIV/AIDS science. 

The 32nd CROI will take place from March 9–12th, 2025 at the Moscone Convention Center in San Francisco, California. The conference will highlight the most significant and impactful original research on HIV and related conditions, while also featuring key findings on SARS-CoV-2 and the mpox virus. Attendees can expect dynamic interactive sessions, engaging poster presentations, and valuable networking opportunities.

Featured Opening Session Speakers

• Bernard Fields Lecture: Frederic D. Bushman (University of Pennsylvania)
• Martin Delaney Presentation: Rebecca Denison (Founder WORLD [Women Organised to Respond to Life-threatening Diseases])
• N’Galy-Mann Lecture: Adeeba Kamarulzaman (Monash University, Malaysia)

Don’t miss the return of Science Spotlights^TM for posters at CROI 2025. In addition to poster walks, PC Poster Picks, and themed discussions, Science Spotlight^TM serve to highlight and elevate poster presentations as presenters engage with CROI attendees. Historically, some of the most important science at CROI has been presented in poster sessions.

Key Discussion Topics 

1. New Antiretroviral Strategies for HIV – Discussions on the latest developments in long-acting therapies, novel drug classes, and potential cure strategies
2. HIV Prevention Advances – Updates on pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), and other prevention strategies ​
3. STI and Co-Infection Research – Focus on sexually transmitted infections (STIs) and their interactions with HIV.
4. Hepatitis and Other Opportunistic Infections – Developments in treating hepatitis B and C alongside HIV.
5. Impact of SARS-CoV-2 on Immunocompromised Patients – Insights into how COVID-19 continues to affect people living with HIV.
6. Equity and Access to Treatment – Discussions on addressing global disparities in HIV care and treatment availability​

For more details, and to register for the event, visit the official CROI website:
CROI Conference

​Disclosure: This article was created by the touchINFECTIOUS DISEASES team utilizing AI as an editorial tool (ChatGPT (GPT-4o) [Large language model]. https://chat.openai.com/chat.) The content was developed and edited by human editors. No funding was received in the publication of this article.

SIGN UP to touchINFECTIOUS DISEASES!

Join our global community today for access to thousands of peer-reviewed articles, expert insights, and learn-on-the-go education across 150+ specialties, plus concise email updates and newsletters so you never miss out.

Click here to REGISTER NOW >>>